Sirolimus is under clinical development by OrphAI Therapeutics and currently in Phase II for Bronchiolitis Obliterans.
RFK Jr. and Influencers Bash Seed Oils, Baffling Nutrition Scientists
Until recently, most Americans had never heard the term “seed oils,” even though they’ve likely cooked with and consumed them for decades. It’s the catchy